Iris Cristina López Santillán

Iris Cristina López Santillán

Auto-generated profile, based on publicly available information

Iris Cristina López Santillán

Universidad Autónoma del Estado de Hidalgo

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
CGCarlos Enrique Galeana-Patiño
Carlos Enrique Galeana-Patiño
MOMario I Ortiz
Mario I Ortiz
Raquel CariñoRaquel Cariño
Raquel Cariño
ILIris Cristina López-Santillán
Iris Cristina López-Santillán
JRJavier Rosas
Javier Rosas
Victor Manuel Muñoz-PérezVictor Manuel Muñoz-Pérez
Victor Manuel Muñoz-Pérez
Background: Preclinical and clinical evidence implies that destructive therapies in local and malignant tissue are frequently used on patients with head and neck cancer. Consequently, the microbiome of the treated and adjacent regions is affected. Disruption of the normal microbiome plays an important role not only in the disease progression but also in its emergence, therefore new therapies involving probiotics, prebiotics, and synbiotics have been developed to control or regulate this microbial disruption. Objective: This review aims to describe the current and potential uses of probiotics at different stages of development of head and neck squamous cell carcinoma, as an adjuvant therapy to prevent common complications such as radiation-induced oral mucositis (RIOM) and its role in other areas. Methods: Currently, there is no widely effective strategy to treat or prevent this kind of cancer. Surgery, radiation therapy, and chemotherapy are the three main treatments for head and neck cancer. Some therapies can also cause long-term health problems, or complications which might change the way you eat, talk, hear and breathe. Results: The main uses for which probiotics have been studied are: Prevention and reduction of severity of RIOM, change in dental plaque to reduce dysbiosis, and reduction of complications in post-operated patients. Potential uses of probiotics include the reduction of disease initiation and progression by reducing local inflammation caused by bacteria and other organisms. Conclusion: The incidence and severity of RIOM may be lessened by probiotics. To establish its uses in additional clinical settings, though, more studies are necessary.

5 January 2022 in Mexican Journal of Medical Research ICSA
Verified
Journal Article
Open access
PDF file
Victor Manuel Muñoz-PérezVictor Manuel Muñoz-Pérez
Victor Manuel Muñoz-Pérez
Raquel CariñoRaquel Cariño
Raquel Cariño
ILIris C. López-Santillán
Iris C. López-Santillán
ASAndres Salas-Casas
Andres Salas-Casas
Inflammation plays an important role to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as inflammatory cells, carry out reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cancer cells within the TME are highly able to change their phenotypic and functional characteristics. Here, we review the relationship between inflammation and infection in cancer origins, and the mechanisms whereby inflammation and infection drive tumor formation. We discuss how infection promotes tumorigenesis related to inflammatory processes typically found in autoimmune diseases, release of inflammatory mediators induced by tumors, inflammation induced by therapy in cancer, and stimuli for induction of inflammation during tumorigenesis, including spatiotemporal considerations. A better understanding of the fundamental rules of engagement that govern the molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of cancer therapies.

1 March 2026 in The Natural Products Journal
Verified
Journal Article
Closed access
PDF file
AEAstrid Espinosa-Sanchez
Astrid Espinosa-Sanchez
ILIris Cristina Lopez-Santillan
Iris Cristina Lopez-Santillan
JDJose Antonio Estefes Duarte
Jose Antonio Estefes Duarte
Antonio Luis García-CorderoAntonio Luis García-Cordero
Antonio Luis García-Cordero
Victor Manuel Muñoz-PérezVictor Manuel Muñoz-Pérez
Victor Manuel Muñoz-Pérez
JRJavier Rosas
Javier Rosas
Background: Hibiscus sabdariffa is a plant used in traditional medicine for intestinal treatments and nowadays for critical diseases like hypertension, diabetes, and cancer. Multidisciplinary approaches have demonstrated, through Hibiscus sabdariffa extracts, anti-inflammation and anti-cancer beneficial properties from compounds like phenols, flavonoids, and anthocyanins that are ubiquitously distributed in whole plants. Objective: The objective of this study is to identify the bioactive compounds and their underlying mechanisms of action that drive the anti-cancer and anti-inflammatory properties of Hibiscus sabdariffa extracts Methods: We searched databases for publications in English from all years that reported beneficial anti-inflammation and anti-cancer properties from Hibiscus sabdariffa extracts and their proposed mechanism of action. We used Pubmed, Google Scholar, Scopus, and ScienceDirect for original articles that included different Hibiscus sabdariffa extracts evaluated for their anti-inflammation, and anti-cancer properties, using the following search terms: “H. sabdariffa”, “H. sabdariffa extracts”, “H. sabdariffa and inflammation”, and “H. sabdariffa and cancer”. Some articles from the reference list were used to collect additional information, and we used 73 articles in total. Results: In general, extracts from Hibiscus sabdariffa are obtained by different methods that affect the final concentration of the compounds. Several in vivo and in vitro experiments show their antiinflammatory and anti-cancer properties. Conclusion: Hibiscus sabdariffa extracts have the potential bioactivity to modulate inflammation and cancer in several cellular and molecular mechanisms of action involving the downregulation of key signaling pathways such as NFκB, MAPK, BCL-2, p53, among others, and the upregulation of protective pathways such as Nrf2. However, research needs to be further evaluated on the exact compounds that have this effect, in order to know if the extracts work individually or synergistically.

5 June 2021 in Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo
Verified
Journal Article
Open access
PDF file
ISIris Cristina López Santillán
Iris Cristina López Santillán
ITIsaí Trejo Teniente
Isaí Trejo Teniente
EOElizabeth Hernández Ortiz
Elizabeth Hernández Ortiz
BLBlanca Estela Jaramillo Loranca
Blanca Estela Jaramillo Loranca
GVGenaro Vargas-Hernández
Genaro Vargas-Hernández
MIMaricela Villanueva Ibáñez
Maricela Villanueva Ibáñez
Actualmente, el cáncer es una de las principales causas de mortalidad y morbilidad a pesar de los múltiples tratamientos disponibles. Por este motivo, continúa la búsqueda de tratamientos novedosos que no afecten negativamente a la calidad de vida del paciente. Las nanopartículas de oro son una alternativa que combina diagnóstico y tratamiento, este último se puede potenciar mediante el uso de moléculas biológicas para su obtención, así como con la conjugación con fármacos anticancerígenos.

5 December 2019 in Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo
Verified
Journal Article
Open access
PDF file
ISIris Cristina López Santillán
Iris Cristina López Santillán
AHAlejandra Hernández-Ceruelos
Alejandra Hernández-Ceruelos
JMJuan D. Meza-Barrera
Juan D. Meza-Barrera
GPGloria M. Pérez-Escalante
Gloria M. Pérez-Escalante
Victor Manuel Muñoz-PérezVictor Manuel Muñoz-Pérez
Victor Manuel Muñoz-Pérez
AFAna Hilda Figueroa
Ana Hilda Figueroa
La genética ha evolucionado enormemente el desarrollo de las ciencias de la salud. Desde los trabajos de Mendel hasta tener gran impactado en progreso de la tecnología actual para el diagnóstico, seguimiento y tratamiento de las enfermedades de origen genético. Además constituye las bases de la estructura, para el entendimiento del genoma humano y la variabilidad de su expression, como el sustento para mantener el estado de homeostasis como sinónimo de salud física y mental.

8 October 2026 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
RCRafael Fabián Chávez-Naranjo
Rafael Fabián Chávez-Naranjo
SLSelene Michele León-León
Selene Michele León-León
AEAstrid Espinosa-Sánchez
Astrid Espinosa-Sánchez
JEJosé Antonio Estefes-Duarte
José Antonio Estefes-Duarte
SOSergio Adrian Ocampo-Ortega
Sergio Adrian Ocampo-Ortega
ILIris Cristina López-Santíllan
Iris Cristina López-Santíllan
Introduction/Objective: Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. It is transmitted through the air and can affect various human tissues, particularly the lungs. TB remains a major global health challenge and a significant public health problem because of its airborne transmission and socioeconomic impact on affected individuals. The objective of this study is to evaluate the implementation of the World Health Organization (WHO) guidelines for the management of drug-susceptible tuberculosis among adults in North American countries. Methods: This study analyzes standardized treatment regimens in Mexico, the United States, and Canada. It assesses the clinical application of antituberculosis drugs, including isoniazid, pyrazinamide, ethambutol, rifampicin, rifapentine, rifabutin, moxifloxacin, and levofloxacin, within their respective national healthcare systems. This research analyzes standardized treatment schemes in Mexico, the United States, and Canada. Results: While treatment protocols in Canada, Mexico, and the United States are consistent with the recommendations of WHO guidelines, specific treatment regimens are tailored to the demographic and clinical needs of each population. Thus, these adaptations may influence healthcare coverage and the overall clinical effectiveness of the interventions. Discussion: Differences in how countries implement their TB control strategies may be associated with several epidemiological patterns. The significance of these findings lies in the possibility that variations in resource availability and differences in the adaptation of clinical guidelines may contribute to the observed epidemiological factors of TB across the region. Conclusion: North American countries have adapted their TB treatment regimens over time in accordance with international standards. However, differences in implementation and resource availability may be associated with variations in TB incidence and mortality rates. Strengthening universal access to TB prevention, diagnosis, and treatment remains essential to reduce catastrophic health expenditures and control the TB epidemic.